Drug Delivery Series: The Market for Transdermal and Transmucosal Drug Delivery Systems: Volume 4

 
   Single User - $1,995
   Hard Copy Mail Delivery - $1,995
   Corporate License - $3,990
   Online Download plus 1 Hard Copy - $2,245


Loading...
Published Jan 1, 2002 | 100 Pages | Pub ID: KLI463092

Order 2 or more reports in this series and save 25-40%! Call 800-298-5699
Drug Delivery Series: The Market for Transdermal and Transmucosal Drug Delivery Systems: Volume 4

This volume will address transdermal and transmucosal drug delivery systems. Both of these systems continue to be of high interest for the delivery of proteins and peptides due to high permeability of mucosal tissue and adaptability of dermal application.

Chapter 1: Executive Summary


    Market Drivers
    Market Size and Growth
    • Total Transdermal/Transmucosal Drug Delivery Market
    • Transdermal/Transmucosal Drug Delivery Only Market

    Competitive and Market Analysis

Chapter 2: Introduction and Overview


    Scope and Methodology
    Reasons for Transdermal/Transmucosal Drug Delivery Systems
    History of Transdermal and Transmucosal Drug Delivery
    Phases of Drug Action
    Topical Drug Delivery
    • Types of Topics Preparations
    • Market Participants

    Transdermal Patch Drug Delivery
    • Membrane-Controlled System
    • Adhesive Dispersion-Type System,
    • Matrix Diffusion-Controlled System
    • Microreservior Dissolution-Controlled System
    • Market Participants

    Electrotransport Drug Delivery
    Iontophoresis
    Transmucosal Drug Delivery
    • Oral Transmucosal Fentanyl Citrate (OTFC)
    • Transmucosal Etomidate
    • Ondansetron ODT

    Buccal Drug Delivery
    Vaginal Drug Delivery

Chapter 3: Trends and Developments


    Adhesive Technology and Issues
    Adhesive Market Issues
    Biotechnological Issues
    Iontophoresis and Phonophoresis
    Developments in Insulin Delivery
    New Developments in Hormone Drug Delivery
    New Mucosal/Buccal Delivery Systems
    Other New Drug Delivery Systems
    Macroflux Technology
    Controlled Thermal Energy Technology
    New Ultrasound Technology
    Combination Delivery Technology

Chapter 4: Market Size and Growth

Chapter 5: Competitive Analysis


    Competitive Landscape
    Market Analysis

Chapter 6: Company Profiles


    3M Pharmaceuticals
    Alza Corporation
    Elan Corporation, plc
    Generex Biotechnology Corporation
    Genetronics Biomedical Corporation
    Labtec GmbH
    Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
    MacroChem Corporation
    Noven Pharmaceuticals, Inc.
    TheraTech, Inc. (Watson Laboratories, Utah)

Chapter 7: Companies in Brief


    Altea Development Corp.
    Anteres Pharma, Inc.
    Atrix Laboratories, Inc.
    Biogel Technology, Inc.
    CeNeS Drug Delivery Ltd.
    SkyePharma Plc
    TransDermal Technologies, Inc.
    Vyteris Inc.

Appendix: Company Directory

List of Exhibits


    Table 2-1: Sequence of Drug Action
    Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Type, 1995-2005
    Table 4-2: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Market Percent Share by Type, 1995-2005
    Table 4-3: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Pharmaceutical and Drug Delivery Component, 1995-2005
    Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005
    Table 5-1: Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Revenues and Market Share by Supplier, 2000
    Figure 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Revenues by Type, 1995-2005
    Figure 4-2: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Share by Type, 2000
    Figure 4-3: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Share by Type, 2005
    Figure 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005
    Figure 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2000
    Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2005
    Figure 5-1: Worldwide Market for Pulmonary Drug Delivery Systems, Market Share by Leading Supplier, 2000

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.